Top News Story
Inflexion advised on Management Due Diligence by Quinn in their buyout of Pharmaspectra
8th October 2019The Quinn Partnership, the UK’s leading Management Due Diligence specialists, have supported Inflexion as they announced their buyout of Pharmaspectra, a leading global provider of medical affairs data to the pharmaceutical and biotech industry. The investment is being made by Inflexion Enterprise Fund IV, Inflexion’s…
Read MoreQuinn consulted on Management Due Diligence as Beechbrook Capital supports design experts Corstorphine + Wright
23rd July 2019Having engaged The Quinn Partnership to provide Management Due Diligence services, Beechbrook Capital has supported the management team of architectural design experts Corstorphine + Wright (‘C+W’) to complete a shareholder realignment. The investment by Beechbrook will allow the second-tier management team to participate in and benefit…
Read MoreQuinn provides Management Due Diligence and Human Capital Review services to Inflexion Private Equity for their investment in leading conveyancing solicitors O’Neill Patient
19th July 2019The Quinn Partnership were delighted to support Inflexion and provide Management Due Diligence and Human Capital Planning support as they announced their investment in legal firm O’Neill Patient Solicitors (ONP), the UK’s leading B2B tech‐enabled provider of property and remortgage conveyancing services. The investment is…
Read More